Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Article Menu
Export Article
More by Authors Links
Article Data
- Views 3212
- Dowloads 139
Case Report
Open AccessHemorrhagic shock as a complication of anticoagulant therapy following the mitral valve replacement
Hemorrhagic shock as a complication of anticoagulant therapy following the mitral valve replacement
1University Hospital Zagreb, Department of anesthesiology, reanimatology and intensive care
2,University Hospital for infective diseases «Fran Mihaljević»
*Corresponding Author(s): TAJANA ZAH E-mail: tajanazah@gmail.com
Abstract
This report describes a case of the hemorrhagic shock in a patient on the anticoagulant therapy supplementing implanted mechanical prosthetic heart valve replacing the mitral valve. The association between hemorrhagic shock, mechanical prosthetic heart valve and anticoagulant therapy is briefly discussed.
Keywords
hemorrhagic shock, mechanical prosthetic heart valve, anticoagulant therapy
Cite and Share
TAJANA ZAH,VIŠNJA IVANČAN,DINKO TONKOVIĆ,ŽELJKO KRZNARIĆ,IGOR KLINAR,VIŠNJA MAJERIĆ KOGLER . Hemorrhagic shock as a complication of anticoagulant therapy following the mitral valve replacement. Signa Vitae. 2007. 2(2);23-24.
References
1. The seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126;287-310.
2. Levine NM, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of anticoagulant treatment Chest 1995;276s-290s.
3. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H. Oral anticoagulants. Mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 1995;108(4Suppl):231S-246.
4. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and predictive factors known at the start of outpatient therapy. Am J Med 1989;87:144-152.
5. Clexane® (enoxaparin) product information. Avensis Pharmaceuticals
Submission Turnaround Time
Top